GlassScriptPhysician profile
Melissa Frank
NPI 1487868782
$9,564.20
in general payments reported to CMS, 2019-2025
42 companies · $2,010 in 2025
The $2,010 reported for 2025 was more than what 94% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,094 · 2022: $1,592 · 2023: $1,942 · 2024: $1,926 · 2025: $2,010.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,789 · Education: $89.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,789.23 |
| Education | $89.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,806.19 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $760.93 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $756.07 | 2021-2025 | Breztri, Farxiga |
| Pfizer INC. | $567.75 | 2021-2025 | |
| Amgen INC. | $537.82 | 2021-2025 | Evenity, Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $530.88 | 2021-2025 | Jardiance, Tradjenta, Synjardy |
| Lilly USA, LLC | $503.38 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $436.67 | 2021-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $343.74 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $322.37 | 2021-2025 | Trintellix |
| Merck Sharp & Dohme LLC | $288.65 | 2021-2024 | Verquvo, Belsomra, Steglatro |
| Astellas Pharma US INC | $288.29 | 2021-2025 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $252.17 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Eisai INC. | $248.82 | 2021-2025 | |
| Amarin Pharma, INC. | $206.18 | 2021-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Frank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.